Your Location：
Home >
Browse articles >
Chinese medicine in US: The regulatory perspective
Updated：2021-08-27
|

    • Chinese medicine in US: The regulatory perspective

    • Chinese Journal of Integrative Medicine   Vol. 3, Issue 2, Pages: 156(1997)

    • DOI：10.1007/BF02935388    

      CLC：

    • Published：1997，

    Scan for full text

  • Gerald K. Shiu. Chinese medicine in US: The regulatory perspective. [J]. Chinese Journal of Integrative Medicine 3(2):156(1997) DOI： 10.1007/BF02935388.

  •  
  •  
FULL TEXT LINK
More>

0

Views

0

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

The importance of scientific research on Fu-Fang Chinese medicine prescriptionsChinese medicine prescriptions
Future view and development of immunology: Exploring the immunology based on Chinese medicine and culture
Cost-effectiveness analysis of combined Chinese medicine and Western medicine for ischemic stroke patients
Objective tongue inspection on 142 liver cancer patients with damp-heat syndrome
Effect of Ermiao Recipe (二妙方) with medicinal guide Angelicae Pubescentis Radix on promoting the homing of bone marrow stem cells to treat cartilage damage in osteoarthritis rats

Related Author

No data

Related Institution

School of Pharmacy & Chemistry, Liverpool John Moore’s University
Georg-August-Universität Göttingen, Göttingen
The Key Laboratory of Geriatrics, Beijing Hospital and Beijing Institute of Geriatrics’ Ministry of Public Health
Medical Informatics Center, Peking University
Department of Hospital Management, Peking University Health Science Center, Peking University
0